DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR OLOPATADINE HYDROCHLORIDE
All Clinical Trials for Olopatadine Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00331500 | Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis | Completed | Alcon Research | Phase 3 | 2006-08-01 | The purpose of this study is to demonstrate that Olopatadine 0.2% is superior to vehicle in the treatment of the signs and symptoms associated with allergic conjunctivitis or rhinoconjunctivitis. |
| NCT00389025 | Mast-Cell Stabilizing Effects of Olopatadine | Completed | Alcon Research | Phase 4 | 2006-10-01 | To assess the effects of olopatadine of the release of mast cell histamine |
| NCT00489398 | Comparison of CL Wear Between Two Allergy Drops | Withdrawn | Merck Sharp & Dohme Corp. | Phase 4 | 2007-07-01 | Comparison of two allergy drops for enhancing comfort and performance of contact lens wear |
| NCT00489398 | Comparison of CL Wear Between Two Allergy Drops | Withdrawn | Hom, Milton M., OD, FAAO | Phase 4 | 2007-07-01 | Comparison of two allergy drops for enhancing comfort and performance of contact lens wear |
| NCT00578331 | Safety Study of Olopatadine Nasal Spray | Completed | Alcon Research | Phase 3 | 2006-12-01 | The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis. |
| NCT00578929 | Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients | Completed | Alcon Research | Phase 3 | 2007-09-01 | A study to demonstrate the superiority of test article nasal spray relative to vehicle nasal spray for the treatment of seasonal allergic rhinitis for a 2 week period in patients aged 6 to 11 years with a history of seasonal allergic rhinitis. |
| NCT00609128 | Allergic Eye Disease Tear Mediators | Unknown status | University of Wisconsin, Madison | N/A | 2000-09-01 | The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary redness, itching, tearing, and swelling of the eyes. Substances released by cells in the affected tissues cause allergic reactions in the eye and elsewhere in the body. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Olopatadine Hydrochloride
Clinical Trial Locations for Olopatadine Hydrochloride
Trials by Country
Clinical Trial Progress for Olopatadine Hydrochloride
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Olopatadine Hydrochloride
Sponsor Name
